$CATX
Perspective Therapeutics, Inc. Stock $catx

$catx Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000143774920002375 Filed on February 12, 2020

Income Statement

Concept	2019 Q4	2018 Q4
Revenue	$2.206M	$1.904M
YoY Change	15.86%	23.96%
Cost Of Revenue	$1.095M	$1.139M
YoY Change	-3.86%	13.33%
Gross Profit	$1.111M	$765.0K
YoY Change	45.23%	44.07%
Gross Profit Margin	50.36%	40.18%
Selling, General & Admin	$1.737M	$1.803M
YoY Change	-3.66%	8.68%
% of Gross Profit	156.35%	235.69%
Research & Development	$277.0K	$414.0K
YoY Change	-33.09%	21.76%
% of Gross Profit	24.93%	54.12%
Depreciation & Amortization	$48.00K	$50.00K
YoY Change	-4.0%	25.0%
% of Gross Profit	4.32%	6.54%
Operating Expenses	$2.014M	$2.194M
YoY Change	-8.2%	9.75%
Operating Profit	-$903.0K	-$1.429M
YoY Change	-36.81%	-2.66%
Interest Expense	$6.000K	$15.00K
YoY Change	-60.0%	50.0%
% of Operating Profit
Other Income/Expense, Net	$6.000K	$15.00K
YoY Change	-60.0%	200.0%
Pretax Income	-$897.0K	-$1.414M
YoY Change	-36.56%	-3.15%
Income Tax
% Of Pretax Income
Net Earnings	-$897.0K	-$1.414M
YoY Change	-36.56%	-3.35%
Net Earnings / Revenue	-40.66%	-74.26%
Basic Earnings Per Share
Diluted Earnings Per Share	-$13.31K	-$21.00K
COMMON SHARES
Basic Shares Outstanding	67.39M
Diluted Shares Outstanding

Balance Sheet

Concept	2019 Q4	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.180M	$7.868M
YoY Change	-59.58%	38.52%
Cash & Equivalents	$3.180M	$3.201M
Short-Term Investments		$0.00
Other Short-Term Assets	$497.0K	$351.0K
YoY Change	41.6%	17.0%
Inventory	$545.0K	$494.0K
Prepaid Expenses
Receivables	$1.409M	$1.107M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.631M	$9.820M
YoY Change	-42.66%	32.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.736M	$1.471M
YoY Change	18.01%	25.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$142.0K	$173.0K
YoY Change	-17.92%	-15.2%
Total Long-Term Assets	$3.302M	$2.091M
YoY Change	57.91%	6.63%
TOTAL ASSETS
Total Short-Term Assets	$5.631M	$9.820M
Total Long-Term Assets	$3.302M	$2.091M
Total Assets	$8.933M	$11.91M
YoY Change	-25.0%	27.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$632.0K	$1.196M
YoY Change	-47.16%	106.21%
Accrued Expenses	$708.0K	$444.0K
YoY Change	59.46%	26.86%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.340M	$1.640M
YoY Change	-18.29%	76.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.452M	$606.0K
YoY Change	139.6%	4.48%
Total Long-Term Liabilities	$1.452M	$606.0K
YoY Change	139.6%	4.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.340M	$1.640M
Total Long-Term Liabilities	$1.452M	$606.0K
Total Liabilities	$2.792M	$2.246M
YoY Change	24.31%	49.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$86.21M	-$82.27M
YoY Change	4.78%	8.8%
Common Stock	$92.35M	$91.94M
YoY Change	0.45%	10.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.141M	$9.665M
YoY Change
Total Liabilities & Shareholders Equity	$8.933M	$11.91M
YoY Change	-25.0%	27.01%

Cashflow Statement

Concept	2019 Q4	2018 Q4
OPERATING ACTIVITIES
Net Income	-$897.0K	-$1.414M
YoY Change	-36.56%	-3.35%
Depreciation, Depletion And Amortization	$48.00K	$50.00K
YoY Change	-4.0%	25.0%
Cash From Operating Activities	-$1.278M	-$1.116M
YoY Change	14.52%	-26.58%
INVESTING ACTIVITIES
Capital Expenditures	-$106.0K	-$115.0K
YoY Change	-7.83%	15.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$2.362M
YoY Change	-100.0%	314.39%
Cash From Investing Activities	-$106.0K	$2.247M
YoY Change	-104.72%	368.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.00K	-120.0K
YoY Change	-90.83%	-400.0%
NET CHANGE
Cash From Operating Activities	-1.278M	-1.116M
Cash From Investing Activities	-106.0K	2.247M
Cash From Financing Activities	-11.00K	-120.0K
Net Change In Cash	-1.395M	1.011M
YoY Change	-237.98%	-201.1%
FREE CASH FLOW
Cash From Operating Activities	-$1.278M	-$1.116M
Capital Expenditures	-$106.0K	-$115.0K
Free Cash Flow	-$1.172M	-$1.001M
YoY Change	17.08%	-29.51%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q4	isr	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	203000
CY2019Q2	isr	Accrued Payroll And Related Taxes Current AccruedPayrollAndRelatedTaxesCurrent	89000
CY2019Q3	isr	Aro Discount Amount Interest Rate AroDiscountAmountInterestRate	5.10
CY2019Q3	isr	Aro Original Obligation Amount AroOriginalObligationAmount	704000
CY2019Q4	isr	Asset Retirement Obligation After Adjustment AssetRetirementObligationAfterAdjustment	555000
	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate	73000
	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate
CY2019Q4	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate
CY2018Q4	isr	Gain Loss On Change In Aro Estimate GainLossOnChangeInAROEstimate
	isr	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	114000
	isr	Increase Decrease In Accrued Payroll And Related Taxes IncreaseDecreaseInAccruedPayrollAndRelatedTaxes	-35000
	isr	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	-109000
	isr	Increase Decrease In Accrued Protocol Expense IncreaseDecreaseInAccruedProtocolExpense	36000
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	14000
	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	87000
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	632000
CY2019Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	683000
	isr	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	21000
	isr	Increase Decrease In Accrued Vacation IncreaseDecreaseInAccruedVacation	-19000
CY2019Q4	isr	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	55000
	isr	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	109000
	isr	Noncash Financing Activities Warrants Issued NoncashFinancingActivitiesWarrantsIssued
	isr	Noncash Financing Activities Warrants Issued NoncashFinancingActivitiesWarrantsIssued	163000
CY2019Q4	isr	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	56000
	isr	Operating Lease Right Of Use Asset Amortization OperatingLeaseRightOfUseAssetAmortization	111000
CY2015Q4	isr	Purchase Agreement Period PurchaseAgreementPeriod	P1Y
CY2019Q4	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
CY2018Q4	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement	19000
	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement
	isr	Research And Development Collaboration Services Net Of Reimbursement ResearchAndDevelopmentCollaborationServicesNetOfReimbursement	45000
CY2019Q4	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	277000
CY2018Q4	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	395000
	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	510000
	isr	Research And Development Proprietary Research And Development ResearchAndDevelopmentProprietaryResearchAndDevelopment	789000
CY2019Q4	isr	Restocking Fee Percentage RestockingFeePercentage	0.5
CY2019Q4	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	11000
CY2018Q4	isr	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodFairValue	52000
CY2019Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	24000
CY2019Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	133000
CY2019Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	163000
CY2019Q2	us-gaap	Accrued Vacation Current AccruedVacationCurrent	142000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7447000
CY2019Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7370000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	92279000
CY2019Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	92105000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	20000
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	25000
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93000
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	97000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	91000
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94000
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	116000
CY2019Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	94000
CY2018Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	97000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	185000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	190000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10790000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10056000
CY2019Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	621000
CY2018Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	590000
CY2019Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	563000
CY2018Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	606000
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	15000
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	16000
CY2019Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	563000
CY2019Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	621000
CY2019Q4	us-gaap	Assets Assets	8933000
CY2019Q2	us-gaap	Assets Assets	9422000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	5631000
CY2019Q2	us-gaap	Assets Current AssetsCurrent	7315000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3180000
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5326000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3201000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5507000
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2781000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3361000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3382000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2146000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	601000
CY2018Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	5830000
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67388047
CY2019Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	67388047
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67388047
CY2019Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	67388047
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	67000
CY2019Q2	us-gaap	Common Stock Value CommonStockValue	67000
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1095000
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1139000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2174000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2177000
	us-gaap	Depreciation Depreciation	77000
	us-gaap	Depreciation Depreciation	65000
CY2018Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	11000
CY2019Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	11000
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2018Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	454000
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P332D
CY2019Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
CY2018Q4	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	23000
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	23000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	23000
CY2019Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1071000
CY2018Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1101000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2168000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2074000
CY2019Q4	us-gaap	Gross Profit GrossProfit	1111000
CY2018Q4	us-gaap	Gross Profit GrossProfit	765000
	us-gaap	Gross Profit GrossProfit	2347000
	us-gaap	Gross Profit GrossProfit	1289000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-51000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-195000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	255000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-85000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-53000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	15000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	18000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	190000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	20000
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7000
CY2019Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	31000
CY2019Q4	us-gaap	Inventory Net InventoryNet	545000
CY2019Q2	us-gaap	Inventory Net InventoryNet	530000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1252000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	237000
CY2019Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	127000
CY2019Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	155000
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	372000
CY2019Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	333000
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	166000
CY2019Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	166000
CY2019Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000
CY2018Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	15000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	26000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	25000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	290000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	290000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	290000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	145000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	134000
CY2019Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2019Q4	us-gaap	Liabilities Liabilities	2792000
CY2019Q2	us-gaap	Liabilities Liabilities	1742000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8933000
CY2019Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9422000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1340000
CY2019Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1121000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7370000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-204000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4043000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1931000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2726000
	us-gaap	Net Income Loss NetIncomeLoss	-1713000
	us-gaap	Net Income Loss NetIncomeLoss	-2922000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-1508000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-1414000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-816000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-897000
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-899000
CY2018Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1416000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1718000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2927000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	229000
CY2019Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	6000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	147000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1118000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	497000
CY2019Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	305000
CY2018Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	26000
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25000
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	2014000
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	2194000
	us-gaap	Operating Expenses OperatingExpenses	4086000
	us-gaap	Operating Expenses OperatingExpenses	4236000
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-903000
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1429000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1739000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2947000
CY2019Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	73000
CY2019Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	889000
CY2019Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1116000
CY2019Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y109D
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	142000
CY2019Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	162000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	89000
CY2019Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	74000
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	11000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	204000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	225000
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	8259000
CY2019Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2000
CY2018Q4	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	2000
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5000
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5000
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
CY2019Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	7000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7381000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	23000
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4418000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9183000
CY2019Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8979000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1736000
CY2019Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1609000
CY2019Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	1409000
CY2019Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	1154000
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	277000
CY2018Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	414000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	510000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	834000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2019Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	181000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-86205000
CY2019Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84492000
CY2019Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2206000
CY2018Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1904000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4521000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3466000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1228000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	6141000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	7680000
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	5030000
CY2019Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	666000
CY2018Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	702000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1481000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1351000
	us-gaap	Share Based Compensation ShareBasedCompensation	185000
	us-gaap	Share Based Compensation ShareBasedCompensation	190000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2956000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.74
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	8250
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	10000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	32000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	26250
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	70750
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	30000
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	155000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	40000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	237500
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	418000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4651000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.64
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	172000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	418000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4651000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.64
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y167D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y259D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y167D
CY2019Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7494000
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	11109000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	9665000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	6955000
CY2019Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67388000
CY2018Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67331000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	67388000
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	66743000

Files In Submission

Name	View Source	Status
0001437749-20-002375-index-headers.html	Edgar Link	pending
0001437749-20-002375-index.html	Edgar Link	pending
0001437749-20-002375.txt	Edgar Link	pending
0001437749-20-002375-xbrl.zip	Edgar Link	pending
ex_170380.htm	Edgar Link	pending
ex_170381.htm	Edgar Link	pending
ex_170383.htm	Edgar Link	pending
ex_170384.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
isr-20191231.xml	Edgar Link	completed
isr-20191231.xsd	Edgar Link	pending
isr-20191231_cal.xml	Edgar Link	unprocessable
isr-20191231_def.xml	Edgar Link	unprocessable
isr-20191231_lab.xml	Edgar Link	unprocessable
isr-20191231_pre.xml	Edgar Link	unprocessable
isr20191231_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CATX
Perspective Therapeutics, Inc. Stock $catx

2019 Q4 Form 10-Q Financial Statement

#000143774920002375 Filed on February 12, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX Perspective Therapeutics, Inc. Stock $catx

2019 Q4 Form 10-Q Financial Statement

#000143774920002375 Filed on February 12, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CATX
Perspective Therapeutics, Inc. Stock $catx